| Literature DB >> 33119878 |
Rebekah E Dadey1,2,3,4, Creg J Workman1,2,3, Dario A A Vignali5,6,7.
Abstract
Regulatory T cells (Tregs) are an immunosuppressive subpopulation of CD4+ T cells that are endowed with potent suppressive activity and function to limit immune activation and maintain homeostasis. These cells are identified by the hallmark transcription factor FOXP3 and the high-affinity interleukin-2 (IL-2) receptor chain CD25. Tregs can be recruited to and persist within the tumor microenvironment (TME), acting as a potent barrier to effective antitumor immunity. This chapter will discuss [i] the history and hallmarks of Tregs; [ii] the recruitment, development, and persistence of Tregs within the TME; [iii] Treg function within TME; asnd [iv] the therapeutic targeting of Tregs in the clinic. This chapter will conclude with a discussion of likely trends and future directions.Entities:
Keywords: CD25; CD39; CTLA4; Cancer immunotherapy; Clinical trials; Foxp3; IL-10; IL-2; IL-35; LAG3; NRP1; Regulatory T cells (Treg); Tolerance; Tumor immunology; Tumor microenvironment (TME)
Mesh:
Substances:
Year: 2020 PMID: 33119878 DOI: 10.1007/978-3-030-49270-0_6
Source DB: PubMed Journal: Adv Exp Med Biol ISSN: 0065-2598 Impact factor: 2.622